Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 1,888.50
+24.00 (1.29%)
Nov 4, 2025, 4:59 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 116.25 billion as of November 4, 2025. Its market cap has increased by 17.83% in one year.
Market Cap
116.25B
Enterprise Value
98.77B
Revenue
23.16B
Ranking
n/a
PE Ratio
13.75
Stock Price
1,888.50
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 116.25B, an increase of 3,055.25%. That is a compound annual growth rate of 14.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 114.77B | 21.05% |
| Dec 30, 2024 | 94.81B | -32.65% |
| Dec 29, 2023 | 140.77B | -26.77% |
| Dec 30, 2022 | 192.23B | 11.72% |
| Dec 30, 2021 | 172.06B | 6.80% |
| Dec 30, 2020 | 161.11B | 67.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.40T |
| Coloplast | 131.86B |
| ALK-Abelló | 47.20B |
| Demant | 45.88B |
| H. Lundbeck | 44.65B |
| Zealand Pharma | 36.09B |
| Ambu A/S | 26.83B |
| Bavarian Nordic | 18.70B |